.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084113

« Back to Dashboard
NDA 084113 describes CHLORPROMAZINE HYDROCHLORIDE, which is a drug marketed by Lederle, Purepac Pharm, Abraxis Pharm, Abbott, Alpharma Us Pharms, Usl Pharma, Pharm Assoc, Eurohlth Intl Sarl, Cycle Pharms Ltd, Wockhardt, Vangard, Sandoz, Pvt Form, Kv Pharm, Ivax Sub Teva Pharms, Watson Labs, Actavis Mid Atlantic, Marsam Pharms Llc, West Ward, and Wyeth Ayerst, and is included in fifty-four NDAs. It is available from fourteen suppliers. Additional details are available on the CHLORPROMAZINE HYDROCHLORIDE profile page.

The generic ingredient in CHLORPROMAZINE HYDROCHLORIDE is chlorpromazine hydrochloride. There are eighteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the chlorpromazine hydrochloride profile page.

Summary for NDA: 084113

Tradename:
CHLORPROMAZINE HYDROCHLORIDE
Applicant:
Usl Pharma
Ingredient:
chlorpromazine hydrochloride
Patents:0
Therapeutic Class:Antiemetics
Antipsychotics
Formulation / Manufacturing:see details

Pharmacology for NDA: 084113

Ingredient-typePhenothiazines

Suppliers and Packaging for NDA: 084113

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHLORPROMAZINE HYDROCHLORIDE
chlorpromazine hydrochloride
TABLET;ORAL 084113 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7683 0615-7683-39 30 TABLET, SUGAR COATED in 1 BLISTER PACK (0615-7683-39)
CHLORPROMAZINE HYDROCHLORIDE
chlorpromazine hydrochloride
TABLET;ORAL 084113 ANDA Sandoz Inc 0781-5915 0781-5915-01 100 TABLET, SUGAR COATED in 1 BOTTLE (0781-5915-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:BPRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc